The dangerous mistake in a hypotensive patient with fever and pulmonary crackles is forcing the case into one shock category. Consider this illustrative presentation: a man in his late 60s with chronic HFrEF and atrial fibrillation arrives confused, febrile, hypoxemic, oliguric, cool, and mottled. A basilar opacity, severe hypotension, and lactate above 5 mmol/L make the stakes obvious—but they do not identify the mechanism.
The useful first working formulation is unstable, undifferentiated shock with possible mixed physiology. Infection may have triggered vasodilation, myocardial depression, atrial fibrillation with loss of atrial contribution, and acute pulmonary congestion. Pulmonary embolism, tamponade, and tension pneumothorax can also mimic parts of the same presentation. Treat the time-critical threats while refining the physiology.
Build the prior before building the label
The baseline history is not a formality. Ask the family about usual mentation, independence, exercise tolerance, orthopnea, home oxygen, recent weight change, and baseline urine output. Clarify medication adherence, recent diuretic changes, oral intake, vomiting or diarrhea, recent hospitalization or antibiotics, aspiration risk, indwelling devices, wounds, pleuritic pain, syncope, cancer, immobility, and prior venous thromboembolism.
This prevents two common errors: calling chronic low ejection fraction “acute cardiogenic shock,” or calling every fever-associated hypotensive state “sepsis.” A possible right lower lobe infiltrate may represent pneumonia, aspiration, atelectasis, or edema. Similarly, a patient with infection can be cold and vasoconstricted once shock is advanced.
| Pattern | Findings that raise suspicion | What POCUS can add |
|---|---|---|
| Distributive or septic | Infectious prodrome, vasodilation, fever, capillary refill abnormality, altered mentation; cold skin is possible late | Hyperdynamic or normal LV, variable filling, focal consolidation, diffuse B-lines from edema or lung injury |
| Cardiogenic | Known or new pump disease, pulmonary edema, JVD, S3, narrow pulse pressure, new murmur, cool extremities | Reduced LV function, regional wall-motion abnormality, B-lines, pleural effusions, venous congestion |
| Obstructive | Syncope, pleuritic symptoms, severe hypoxemia, unilateral absent breath sounds, muffled heart sounds, disproportionate JVD | RV dilation or septal flattening suggesting right-heart strain, pericardial effusion with chamber collapse, absent lung sliding with a compatible pneumothorax pattern, lower-extremity DVT |
JVD is useful when present, but its absence is not an exclusion test—obesity, low circulating volume, positioning, and technical limitations all matter. No single bedside sign reliably separates these categories.
Let POCUS answer treatment questions
A focused “pump, tank, and pipes” examination should be performed early and repeated after major interventions. Look at global LV function, RV size and systolic function, the pericardium, lung sliding, B-lines, pleural fluid, focal consolidation, and lower-extremity veins when pulmonary embolism is plausible. An IVC view may contribute context, but it should not be treated as a stand-alone measurement of volume status.
A hyperdynamic LV supports low afterload or low preload; it does not prove sepsis. A poor LV may be the patient’s chronic baseline, and a patient with HFrEF can still have distributive shock. The key question is not “What is the ejection fraction?” but “What physiology is limiting perfusion right now, and will the next intervention help or harm?”
Resuscitate while the differential is still open
When septic shock is possible or probable, obtain blood cultures as soon as possible—ideally before antimicrobials without delaying treatment—and give appropriate empiric antimicrobial therapy immediately, ideally within 1 hour of recognition. Current 2026 adult sepsis guidance suggests at least 30 mL/kg of IV crystalloid during the first 3 hours for sepsis-induced hypoperfusion or septic shock, but it also emphasizes patient context, frequent reassessment, and avoiding both under- and over-resuscitation. In a patient with HFrEF, pulmonary congestion, and severe hypotension, that recommendation is not permission to give fluid blindly.
Use a dynamic test such as passive leg raise with a stroke-volume or cardiac-output response when available. Give an initial crystalloid bolus with close reassessment when fluid responsiveness is plausible, and start vasopressor support early when hypotension is profound or worsening. In unstable septic shock, fluid and vasopressor therapy may need to begin concurrently. A peripheral norepinephrine infusion can be started through a suitable IV with site monitoring while reliable central access is arranged rather than delaying vasopressor therapy.
Norepinephrine is the preferred initial vasopressor for septic shock and is a reasonable bridge while mixed physiology is being clarified. Dopamine is particularly unattractive in a patient with an active tachyarrhythmia because randomized shock data found more arrhythmic events than with norepinephrine and raised a mortality signal in a cardiogenic-shock subgroup.
If norepinephrine requirements are escalating in septic shock, vasopressin is an adjunct—not a replacement for norepinephrine, antibiotics, source control, or evaluation for persistent low-output physiology. If arterial pressure is restored but hypoperfusion persists and cardiac dysfunction is demonstrated, an inotrope may be needed in addition to vasopressor support. Dobutamine added to norepinephrine or epinephrine as the vasoactive strategy are guideline-supported options, but this is an ICU-level decision requiring close reassessment.
The rhythm can be cause, consequence, or both
Atrial fibrillation with rapid ventricular response may worsen filling and forward flow in a patient with HFrEF, but it may also be a stress response to infection, hypoxemia, or catecholamine excess. Do not reflexively give an AV-nodal blocker to a patient with shock and decompensated pump function. If the arrhythmia is clearly responsible for hemodynamic instability, immediate synchronized cardioversion is the appropriate rhythm-control pathway; otherwise, treat the trigger and reassess the rate as perfusion improves.
Read lactate as a signal, not a verdict
A lactate of 5 mmol/L identifies a high-risk patient, not a specific shock type. Low-flow hypoperfusion, catecholamine-driven glycolysis, impaired hepatic clearance, seizures, beta-agonism, and other processes can contribute. Lactate may remain elevated after blood pressure improves because macro-hemodynamics and microcirculatory function do not recover at the same speed.
A normal blood pressure is a resuscitation milestone—not proof that the shock has ended.
Trend lactate alongside capillary refill, skin temperature and mottling, mental status, urine output, respiratory status, bedside cardiac findings, and vasopressor dose. Do not continue fluid solely to normalize lactate, especially when pulmonary congestion is increasing.
Common traps at the bedside
- Fever plus an infiltrate does not prove that all hypotension is septic.
- HFrEF plus crackles does not prove that infection is absent.
- Warm versus cold skin is a pattern, not a diagnostic criterion.
- A single IVC measurement cannot determine fluid responsiveness.
- A normal MAP does not guarantee restored tissue perfusion.
- The 30 mL/kg suggestion should not become a checkbox that overrides serial physiology.
- Dopamine is not a benign solution for hypotension in a patient with tachyarrhythmia.
- A reassuring first ultrasound should not end the examination; shock physiology evolves.
Practical takeaways
- Describe the syndrome and severity first: this patient has shock with end-organ hypoperfusion before the final cause is known.
- Consider mixed physiology when infection, chronic pump disease, pulmonary congestion, and arrhythmia coexist.
- Use POCUS to help choose and prioritize fluid, vasopressor, inotropy, decompression, or urgent imaging—not simply to document an ejection fraction.
- Start appropriate antimicrobials promptly when septic shock is probable, but do not stop evaluating cardiogenic and obstructive causes.
- Use norepinephrine early, add vasopressin when septic shock requires escalating norepinephrine, and reassess for inotropy when pressure improves but perfusion does not.
- Treat lactate as one part of a perfusion trend, never as permission for unlimited fluid.